148-53-8

应用筛选条件

关键词:'148-53-8'

显示 1-5 共 5 条结果关于 "148-53-8" 范围论文

An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.

Leonel Maldonado et al.

Oncotarget, 5(14), 5218-5233 (2014-07-02)

By a candidate gene approach, we analyzed the promoter methylation (PM) of 8 genes genes (ARF, TIMP3, RAR-β2, NID2, CCNA1, AIM1, CALCA and CCND2) by quantitative methylation specific PCR (QMSP) in DNA of 17 non-recurrent and 19 recurrent noninvasive low

Wading bird guano contributes to Hg accumulation in tree island soils in the Florida Everglades.

Yingjia Zhu et al.

Environmental pollution (Barking, Essex : 1987), 184, 313-319 (2013-10-02)

Tree islands are habitat for wading birds and a characteristic landscape feature in the Everglades. A total of 93 surface soil and 3 soil core samples were collected from 7 degraded/ghost and 34 live tree islands. The mean Hg concentration

HDAC8, A Potential Therapeutic Target, Regulates Proliferation and Differentiation of Bone Marrow Stromal Cells in Fibrous Dysplasia.

Tao Xiao et al.

Stem cells translational medicine, 8(2), 148-161 (2018-11-15)

Fibrous dysplasia (FD) is a disease of postnatal skeletal stem cells caused by activating mutations of guanine nucleotide-binding protein alpha-stimulating activity polypeptide (GNAS). FD is characterized by high proliferation and osteogenesis disorder of bone marrow stromal cells (BMSCs), resulting in

Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.

Christiana Smith et al.

PloS one, 10(5), e0127062-e0127062 (2015-05-23)

Six weeks of zidovudine (ZDV) is recommended for postnatal prophylaxis of HIV-exposed infants, but combination antiretrovirals are indicated if HIV transmission risk is increased. We investigated the frequency and severity of adverse events (AE) in infants receiving multiple drug prophylaxis

Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.

Edward Chow et al.

The Lancet. Oncology, 16(15), 1463-1472 (2015-10-23)

Pain flare occurs after palliative radiotherapy, and dexamethasone has shown potential for prevention of such flare. We aimed to compare the efficacy of dexamethasone with that of placebo in terms of reduction of incidence of pain flare. In this double-blind

1/1